Verified factor-similar pair

AVUV vs SLYV

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB HML RMW
Similarity score
86
Verified similar

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • AVUV has the higher backtested relative Sharpe (1.114 vs 1.104).
  • SLYV has the lower published fee (0.15% vs 0.25%).
  • SLYV is cheaper on dividend valuation (127 vs 132, where 100 is each fund's historical median).
  • AVUV has the stronger regression fit (adjusted R-squared 0.976 vs 0.957).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

AVUV

Avantis U.S. Small Cap Value ETF
SMB HML RMW
Adj. R2
0.976
Rel. Sharpe
1.114
Mkt beta
1.06
AUM
US$24.8B
MER
0.25%
Valuation
132

SLYV

State Street SPDR S&P 600 Small Cap Value ETF
SMB HML RMW
Adj. R2
0.957
Rel. Sharpe
1.104
Mkt beta
0.98
AUM
US$4.2B
MER
0.15%
Valuation
127

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
AVUV
+0.90
|t|
+16.5
SLYV
+0.80
|t|
+28.4
diff +0.10
HML
AVUV
+0.53
|t|
+11.7
SLYV
+0.39
|t|
+13.2
diff +0.15
RMW
AVUV
+0.27
|t|
+5.0
SLYV
+0.24
|t|
+7.3
diff +0.03
CMA
AVUV
-0.04
|t|
-0.7
SLYV
+0.09
|t|
+2.1
diff -0.13
UMD
AVUV
-0.01
|t|
-0.3
SLYV
-0.03
|t|
-1.9
diff +0.02

Why This Pair Matches

Exposure level
82
Exposure shape
99
Mkt beta diff
0.08
Rel. Sharpe diff
0.009

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

AVUV fund page SLYV fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.